Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalFrontiers in Pharmacology
Volume7
DOIs
Publication statusPublished - 24 May 2016

Cite this